Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$856M |
| 2 |
Meta Platforms (Facebook)
META
|
+$647M |
| 3 |
NVIDIA
NVDA
|
+$615M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$304M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.03B |
| 2 |
UnitedHealth
UNH
|
+$686M |
| 3 |
Tesla
TSLA
|
+$387M |
| 4 |
Abbott
ABT
|
+$380M |
| 5 |
Chevron
CVX
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.26% |
| 2 | Healthcare | 16.96% |
| 3 | Consumer Discretionary | 12.82% |
| 4 | Consumer Staples | 9.14% |
| 5 | Industrials | 9.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVBG
1801
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.74M | ﹤0.01% |
102,000
+3,600
| +4% | +$97.1K |
|
1802
GCM Grosvenor
GCMG
$754M
| $2.74M | ﹤0.01% |
363,400
+52,100
| +17% | +$388K |
|
1803
ARK Innovation ETF
ARKK
$5.64B
| $2.74M | ﹤0.01% |
62,000
-19,000
| -23% | -$755K |
|
1804
i3 Verticals
IIIV
$412M
| $2.73M | ﹤0.01% |
119,415
+6,115
| +5% | +$143K |
|
1805
Integra LifeSciences
IART
$1.29B
| $2.73M | ﹤0.01% |
66,300
-98,191
| -60% | -$4.73M |
|
1806
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
| $2.73M | ﹤0.01% |
+92,700
| New | +$2.71M |
|
1807
F&G Annuities & Life
FG
$3.79B
| $2.72M | ﹤0.01% |
+109,600
| New | +$2.15M |
|
1808
Howard Hughes
HHH
$3.81B
| $2.71M | ﹤0.01% |
36,086
-20,980
| -37% | -$1.52M |
|
1809
Expensify
EXFY
$176M
| $2.71M | ﹤0.01% |
339,700
+215,900
| +174% | +$1.58M |
|
1810
Clearwater Paper
CLW
$339M
| $2.71M | ﹤0.01% |
86,500
-4,200
| -5% | -$136K |
|
1811
QuinStreet
QNST
$890M
| $2.7M | ﹤0.01% |
305,700
-115,500
| -27% | -$1.16M |
|
1812
Unisys
UIS
$209M
| $2.69M | ﹤0.01% |
676,233
+133,600
| +25% | +$530K |
|
1813
Global X S&P 500 Covered Call ETF
XYLD
$3.24B
| $2.69M | ﹤0.01% |
65,400
+13,991
| +27% | +$569K |
|
|
PWOD
1814
DELISTED
Penns Woods Bancorp
PWOD
| $2.68M | ﹤0.01% |
107,219
-3,738
| -3% | -$90.6K |
|
|
HRT
1815
DELISTED
HireRight Holdings Corporation
HRT
| $2.68M | ﹤0.01% |
236,900
+113,800
| +92% | +$1.19M |
|
1816
Palomar
PLMR
$3.55B
| $2.68M | ﹤0.01% |
46,100
+25,100
| +120% | +$1.34M |
|
1817
iShares MSCI USA Quality Factor ETF
QUAL
$46.4B
| $2.67M | ﹤0.01% |
19,800
+6,800
| +52% | +$865K |
|
1818
Oric Pharmaceuticals
ORIC
$1.15B
| $2.67M | ﹤0.01% |
343,700
-400
| -0.1% | -$2.27K |
|
1819
First Trust Smith Unconstrained Bond ETF
UCON
$3.27B
| $2.65M | ﹤0.01% |
109,700
+37,700
| +52% | +$918K |
|
1820
G-III Apparel Group
GIII
$1.54B
| $2.65M | ﹤0.01% |
137,403
-41,100
| -23% | -$707K |
|
1821
Olema Pharmaceuticals
OLMA
$1B
| $2.65M | ﹤0.01% |
292,900
+35,700
| +14% | +$216K |
|
1822
Cullinan Oncology
CGEM
$1.01B
| $2.64M | ﹤0.01% |
245,600
+6,400
| +3% | +$68K |
|
1823
FormFactor
FORM
$8.28B
| $2.64M | ﹤0.01% |
+77,168
| New | +$2.31M |
|
1824
FLEX LNG
FLNG
$1.69B
| $2.63M | ﹤0.01% |
86,284
+48,055
| +126% | +$1.54M |
|
|
PLYM
1825
DELISTED
Plymouth Industrial REIT
PLYM
| $2.63M | ﹤0.01% |
114,412
-28,800
| -20% | -$616K |
|
Similar funds
Renaissance Technologies's Q2 2023 Portfolio in Review
As of Q2 2023, Renaissance Technologies held 4,468 positions worth $69.4B, down 7.9% from $75.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $8.1B in Q2 2023, closing 599 positions and reducing 1,691 holdings. Its most notable exit was UnitedHealth, an estimated $686M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Berkshire Hathaway Class A worth $316M.
- Renaissance Technologies's largest Q2 2023 buy was Berkshire Hathaway Class A: 611 shares worth $316M.
- Renaissance Technologies added most to Apple in Q2 2023, an estimated $856M increase.
- Renaissance Technologies's biggest Q2 2023 reduction was Amazon, cutting an estimated $1.03B.
- Renaissance Technologies fully exited UnitedHealth in Q2 2023, selling an estimated $686M.
- Renaissance Technologies's ten largest holdings make up 12% of its $69.4B portfolio in Q2 2023.
- Renaissance Technologies opened 542 new positions and closed 599 in Q2 2023.
- Renaissance Technologies's portfolio value fell 7.9% quarter-over-quarter to $69.4B.
Based on Renaissance Technologies's 13F filing for Q2 2023, filed 11 Aug 2023.